Welch & Forbes LLC Amgen Inc Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Amgen Inc stock. As of the latest transaction made, Welch & Forbes LLC holds 25,555 shares of AMGN stock, worth $6.73 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,555

Previous 25,925 1.43%

Holding current value

$6.73 Million

Previous $8.1 Million 1.65%

% of portfolio

0.11%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $114,470 - $124,830	-370 Reduced 1.43%	25,555 $8.23 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $9,721 - $11,814	-37 Reduced 0.14%	25,925 $8.1 Million
Q1 2024 May 02, 2024	BUY	$268.87 - $324.56 $79,585 - $96,069	296 Added 1.15%	25,962 $7.38 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.06%	25,666 $7.39 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $652,014 - $809,493	-2,982 Reduced 10.4%	25,681 $6.9 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $29,354 - $34,711	-137 Reduced 0.48%	28,663 $6.36 Million
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $89,638 - $109,254	-397 Reduced 1.36%	28,800 $6.96 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $18,093 - $22,989	-79 Reduced 0.27%	29,197 $7.67 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $265,760 - $299,729	-1,184 Reduced 3.89%	29,276 $6.6 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $164,034 - $182,542	-711 Reduced 2.28%	30,460 $7.41 Million
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $24,119 - $26,682	-110 Reduced 0.35%	31,171 $7.54 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $719,348 - $823,229	-3,617 Reduced 10.36%	31,281 $7.04 Million
Q3 2021 Oct 13, 2021	SELL	$212.27 - $248.7 $301,635 - $353,402	-1,421 Reduced 3.91%	34,898 $7.42 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $84,088 - $93,290	360 Added 1.0%	36,319 $8.85 Million
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $321,547 - $374,711	-1,449 Reduced 3.87%	35,959 $8.95 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $93,476 - $111,313	-432 Reduced 1.14%	37,408 $8.6 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $154,634 - $171,966	-659 Reduced 1.71%	37,840 $9.62 Million
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $308,187 - $378,188	-1,558 Reduced 3.89%	38,499 $9.08 Million
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $1.02 Million - $1.35 Million	5,573 Added 16.16%	40,057 $8.12 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $26,489 - $34,048	140 Added 0.41%	34,484 $8.31 Million
Q3 2019 Oct 11, 2019	BUY	$174.11 - $208.62 $46,661 - $55,910	268 Added 0.79%	34,344 $6.65 Million
Q2 2019 Jul 12, 2019	SELL	$166.7 - $195.41 $6,668 - $7,816	-40 Reduced 0.12%	34,076 $6.28 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $851,897 - $960,274	-4,710 Reduced 12.13%	34,116 $6.48 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $147,715 - $172,431	-828 Reduced 2.09%	38,826 $7.56 Million
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $63,925 - $72,067	-345 Reduced 0.86%	39,654 $8.22 Million
Q2 2018 Jul 16, 2018	SELL	$166.05 - $186.51 $4,815 - $5,408	-29 Reduced 0.07%	39,999 $7.38 Million
Q1 2018 Apr 12, 2018	SELL	$169.43 - $198.0 $230,763 - $269,676	-1,362 Reduced 3.29%	40,028 $6.82 Million
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $13,334 - $14,898	79 Added 0.19%	41,390 $7.2 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $6.91 Million - $7.89 Million	41,311	41,311 $7.7 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account